European MedTech funding rose in 2025 but concentrated in fewer, larger AI-led rounds. Early stages remain competitive as investors price in MDR timelines, AI-Act obligations, and payer-driven evidence. Given new shifts in the landscape, how did investors allocate capital in 2025? What trends did we see emerge, and how are they influencing expectations for 2026? This session will provide investors’ perspectives on what’s driving funding decisions up to Series B, which sectors are gaining traction, and how start-ups can position themselves for the coming year.
Investment trends: Looking back on 2025 & forward in 2026
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 9:15 AM
- 10:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
- Pauline de Breteuil, Partner, UI Investissement
- Eric Bernos, Investment Director, Captech
- Daniel Auriel, Fundraising Specialist, 28DIGITAL
- Elizabeth Jennings, Managing Partner, Venture Atlas Labs
- Ariane De Marcillac, Associate, Gilde Healthcare
